Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite.
暂无分享，去创建一个
H. Mitsuya | K. Maeda | M. Toda | H. Habashita | Shiro Shibayama | Rena Nishizawa | Toshihiko Nishiyama | K. Hisaichi | Chiaki Minamoto | Y. Takaoka | Hideaki Tada | K. Sagawa | D. Fukushima | N. Matsunaga